肝病治疗仪治疗慢性乙型肝炎的临床观察  

Clinical observation of liver disease therapy instrument in the treatment of chronic hepatitis B

作　　者：胡日旺[1] 

机构地区：[1]山西省大同市第四人民医院,山西大同037008

出　　处：《临床医药文献电子杂志》2015年第4期626-627,共2页Electronic Journal of Clinical Medical Literature

摘　　要：目的：探讨在慢性乙型肝炎患者中，应用肝病治疗仪治疗方案的疗效。方法选取我院于2013年7月～2014年6月收治的慢性乙型肝炎患者80例进行分析，将其随机分为对照组（40例）和观察组（40例）。对照组采用常规药物治疗方案，观察组采用肝病治疗仪治疗方案。观察两组患者的疗效。结果两组患者在乏力、腹胀、纳差、黄疸、肝区不适等临床症状的治疗有效率上相比差异无统计学意义（P＞0.05）。但观察组患者治疗后的肝功能指标明显优于对照组，不良反应的发生率（5.0%）明显低于对照组（17.5%），差异具有统计学意义（P＜0.05）。结论对于慢性乙型肝炎患者而言，采用常规药物治疗和肝病治疗仪进行治疗，疗效相当，但使用肝病治疗仪患者的肝功能恢复更加明显，不良反应发生率更低，值得推荐使用。Objective To study the in patients with chronic hepatitis b, liver disease treatment instrument application the clinical efifcacy of treatment.MethodsTo select our hospital from July 2013 to June 2014, 80 cases of patients with chronic hepatitis b were analyzed, and its were randomly divided into control group （40 cases） and observation group （40 cases）. Control group using conventional drug treatment, observation group with liver disease therapeutic treatment. To observe clinical therapeutic effect of two groups of patients.ResultsTwo groups of patients in weakness, abdominal distention, poor appetite, jaundice, liver area unwell on the treatment of clinical symptoms, such as efifcient compared with the difference, is not statistically signiifcant （P＆gt;0.05）. But the observation group of patients after treatment of liver function index is superior to control group, the incidence of adverse reactions （5.0%）, signiifcantly lower than the control group （17.5%）, statistically signiifcant differences （P＆lt;0.05）, with statistical signiifcance.ConclusionFor patients with chronic hepatitis b, the conventional drug therapy and liver disease therapeutic treatment, clinical efifcacy, but use the liver function recovery of patients with liver disease therapeutic apparatus more apparent, lower incidence of adverse reactions, recommended to use.

关 键 词：慢性乙型肝炎 肝病治疗仪 药物治疗 临床疗效 

分 类 号：R473.5[医药卫生—护理学]